Alamar Biosciences ALMR
$26.48 −$2.20 (-7.67%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.50 +0.08%
Open$28.25
Prev close$28.68
Day range$26.24 – $28.25
Volume712.6K
Market cap$1.84B
P/E (TTM)–
Dividend yield–
ALMR Stock News
Headlines matching Alamar Biosciences or the ALMR ticker, most recent first.
- Analysts Offer Insights on NA Companies: Alamar Biosciences, Inc. (ALMR), NIQ Global Intelligence PLC (NIQ) and Amentum Holdings, Inc. (AMTM)
- Stifel Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Raises Target Price to $32 Positive
- J.P. Morgan Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Raises Target Price to $35 Positive
- Analysts Offer Insights on NA Companies: Alamar Biosciences, Inc. (ALMR), NIQ Global Intelligence PLC (NIQ) and ServiceTitan, Inc. Class A (TTAN)
- BofA Securities Maintains Alamar Biosciences(ALMR.US) With Hold Rating, Raises Target Price to $31 Positive
- J.P. Morgan Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Raises Target Price to $32 Positive
- TD Cowen Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Raises Target Price to $34 Positive
- Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX) Positive
- Stifel Maintains Alamar Biosciences(ALMR.US) With Buy Rating, Maintains Target Price $28
- Leerink Partners Initiates Alamar Biosciences(ALMR.US) With Buy Rating, Announces Target Price $35
- Analysts Offer Insights on NA Companies: AEVEX Corp. Class A (AVEX) and Alamar Biosciences, Inc. (ALMR)
- A Quick Look at Today's Ratings for Alamar Biosciences(ALMR.US), With a Forecast Between $27 to $35
- Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$3.33 Million in Common Stock
- BofA Securities Maintains Alamar Biosciences(ALMR.US) With Hold Rating
- Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$5.68 Million in Common Stock
No comments yet — be the first to weigh in on ALMR.
Sign in to join the discussion.